Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (âInnateâ or the âCompanyâ) today reported its business update and consolidated
Open original source